Proteomic signatures of angiogenesis in androgen-independent prostate cancer

Prostate

Volumn 74, Issue 3, 2014, Pages 260-272

  Karagiannis, George S ^a,b   Saraon, Punit ^a,b   Jarvi, Keith A ^b   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

androgen independent cancer; chemokines; mass spectrometry; prostate cancer angiogenesis; prostate cancer proteomics

Indexed keywords

CD31 ANTIGEN; COMPLEMENTARY DNA; CXCL3 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; LIGAND; PROTEOME; RNA; VON WILLEBRAND FACTOR;

ANDROGEN INDEPENDENT PROSTATE CANCER; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METASTASIS; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

EID: 84892439035     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22747     Document Type: Article

References (46)

1. Folkman J,. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence. Endocrinology 1998; 139: 441-442.
2. Stewart RJ, Panigrahy D, Flynn E, Folkman J,. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol 2001; 165: 688-693.
3. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E,. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999; 103: 159-165.
4. Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE,. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 2000; 55: 99-109.
5. Shabisgh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff ET, Heitjan D, Kiss A, Buttyan R,. Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 1999; 140: 1920-1926.
6. Haggstrom S, Stattin P, Wikstrom P, Bergh A, Damber JE,. Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancer. BJU Int 2001; 88: 110-116.
7. Franck-Lissbrant I, Haggstrom S, Damber JE, Bergh A,. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 1998; 139: 451-456.
8. Westin P, Stattin P, Damber JE, Bergh A,. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 1995; 146: 1368-1375.
9. Stattin P, Westin P, Damber JE, Bergh A,. Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer. Br J Cancer 1998; 77: 670-675.
10. Saraon P, Jarvi K, Diamandis EP,. Molecular alterations during progression of prostate cancer to androgen independence. Clin Chem 2011; 57: 1366-1375.
11. Nicholson B, Theodorescu D,. Angiogenesis and prostate cancer tumor growth. J Cell Biochem 2004; 91: 125-150.
12. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J,. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-409.
13. Haggstrom S, Bergh A, Damber JE,. Vascular endothelial growth factor content in metastasizing and nonmetastasizing dunning prostatic adenocarcinoma. Prostate 2000; 45: 42-50.
14. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
15. Bergers G, Benjamin LE,. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-410.
16. Baeriswyl V, Christofori G,. The angiogenic switch in carcinogenesis. Semin Cancer Biol 2009; 19: 329-337.
17. Gustavsson H, Welen K, Damber JE,. Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. Prostate 2005; 62: 364-373.
18. Gustavsson H, Jennbacken K, Welen K, Damber JE,. Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer. Prostate 2008; 68: 161-170.
19. Vázquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML,. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999; 274: 23349-23357.
20. Nicholson B, Schaefer G, Theodorescu D,. Angiogenesis in prostate cancer: biology and therapeutic opportunities. Cancer Metastasis Rev 2001; 20: 297-319.
21. Saraon P, Musrap N, Cretu D, Karagiannis GS, Batruch I, Smith C, Drabovich AP, Trudel D, van der Kwast T, Morrissey C, Jarvi KA, Diamandis EP,. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer. J Biol Chem 2012; 287: 34019-34031.
22. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS,. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res 2008; 68: 4447-4454.
23. Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP,. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget 2012; 3: 267-285.
24. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C,. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: D412-D416.
25. Drabovich AP, Pavlou MP, Dimitromanolakis A, Diamandis EP,. Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay. Mol Cell Proteomics 2012; 11: 422-434.
26. Collier TS, Sarkar P, Franck WL, Rao BM, Dean RA, Muddiman DC,. Direct comparison of stable isotope labeling by amino acids in cell culture and spectral counting for quantitative proteomics. Anal Chem 2010; 82: 8696-8702.
27. Karagiannis GS, Pavlou MP, Diamandis EP,. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol Oncol 2010; 4: 496-510.
28. Sadler JE,. Biochemistry and genetics of vonWillebrand factor. Annu Rev Biochem 1998; 67: 395-424.
29. Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL,. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res 2008; 68: 1809-1819.
30. Nguyen H, Ivanova VS, Kavandi L, Rodriguez GC, Maxwell GL, Syed V,. Progesterone and 1,25-dihydroxy vitamin D inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F. Mol Cancer Res 2011; 9: 1479-1492.
31. Ligi I, Simoncini S, Tellier E, Vassallo PF, Sabatier F, Guillet B, Lamy E, Sarlon G, Quemener C, Bikfalvi A, Marcelli M, Pascal A, Dizier B, Simeoni U, Dignat-George F, Anfosso F,. A switch toward angiostatic gene expression impairs the angiogenic properties of endothelial progenitor cells in low birth weight preterm infants. Blood 2011; 118: 1699-1709.
32. Hood JL, San RS, Wickline SA,. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011; 71: 3792-3801.
33. Chamoto K, Gibney BC, Lee GS, Lin M, Collings-Simpson D, Voswinckel R, Konerding MA, Tsuda A, Mentzer SJ,. CD34+ progenitor to endothelial cell transition in post-pneumonectomy angiogenesis. Am J Respir Cell Mol Biol 2012; 46: 283-289.
34. Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M,. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Int J Urol 2007; 14: 233-239.
35. Van Obberghen-Schilling E, Tucker RP, Saupe F, Gasser I, Cseh B, Orend G,. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 2011; 55: 511-525.
36. Folkman J,. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
37. Jang TL, Schaeffer AJ,. The role of cytokines in prostatitis. World J Urol 2003; 21: 95-99.
38. Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA,. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006; 42: 768-778.
39. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD, Strieter RM,. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999; 154: 1503-1512.
40. Engl T, Relja B, Blumenberg C, Müller I, Ringel EM, Beecken WD, Jonas D, Blaheta RA,. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci 2006; 78: 1784-1793.
41. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D,. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270: 27348-27357.
42. Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM,. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005; 175: 5351-5357.
43. Wente MN, Keane MP, Burdick MD, Friess H, Büchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ,. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 2006; 241: 221-227.
44. Baird AM, Gray SG, O'Byrne KJ,. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS ONE 2011; 6: e14593.
45. Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, Brosh R, Buganim Y, Goldfinger N, Klocker H, Schalken JA, Rotter V,. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 2009; 30: 698-705.
46. Gallagher PG, Bao Y, Prorock A, Zigrino P, Nischt R, Politi V, Mauch C, Dragulev B, Fox JW,. Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 2005; 65: 4134-4146.